Fig. 7
From: Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
Tryptase+/CPA3 + mast cells association with progression-free survival. Post-NACT (A) total, (B) intraepithelial, and (C) stromal Tryptase+/CPA3 + levels stratified by progression-free survival 12-month cut-off. Statistically significant differences determined by Student T-test. NACT, neoadjuvant chemotherapy, *p < 0.05, as indicated, ns, non-significant